Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1
Conditions: Breast Cancer; HER2-positive Breast Cancer; HER-2 Gene Amplification; HER2 Positive Breast Carcinoma; HER-2 Protein Overexpression; Breast Cancer, Male; Breast Cancer Female Intervention: Biological: HER2 DC1 Vaccine Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Pennies in Action Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials